Cleared Traditional

K983332 - NORTHEAST PROTON THERAPY CENTER

K983332 is an FDA 510(k) clearance for NORTHEAST PROTON THERAPY CENTER, manufactured by Massachusetts General Hospital. The device is a Class 2 Radiology device with product code LHN cleared through the Traditional 510(k) pathway after a 1032-day FDA review.

K983332 · Massachusetts General Hospital · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2001
Decision
1032d
Days
Class 2
Risk

K983332 is an FDA 510(k) clearance for the NORTHEAST PROTON THERAPY CENTER. Classified as System, Radiation Therapy, Charged-particle, Medical (product code LHN), Class II - Special Controls.

Submitted by Massachusetts General Hospital (Washington, US). The FDA issued a Cleared decision on July 20, 2001 after a review of 1032 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.5050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Radiology submissions.

View all Massachusetts General Hospital devices

FDA 510(k) Submission Details - K983332

510(k) Number K983332 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 22, 1998
Decision Date July 20, 2001
Days to Decision 1032 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
925d slower than avg
Panel avg: 107d · This submission: 1032d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LHN Device Classification - Class 2, Special Controls

Product Code LHN System, Radiation Therapy, Charged-particle, Medical
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.5050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LHN System, Radiation Therapy, Charged-particle, Medical

All 43
Devices cleared under the same product code (LHN) and FDA review panel - the closest regulatory comparables to K983332.
ATLAS-BASED AUTOSEGMENTATION
K080799 · Computerized Medical Systems, Inc. · Aug 2008
IPLAN RT IMAGE
K080886 · Brainlab AG · Jun 2008
INTUITION IMAGE
K032511 · Brainlab AG · Jan 2004
PROTON THERAPY SYSTEM
K983024 · Ion Beam Applications S.A. · Jul 2001
TREATVISION
K002194 · Varian Medical Systems, Inc. · Aug 2000
EXACTRAC (BRAINLAB PATIENT POSITIONING SYSTEM)
K983660 · Brainlab, Inc. · Jul 1999